摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,7-dimethoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline | 30001-98-0

中文名称
——
中文别名
——
英文名称
6,7-dimethoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline
英文别名
6,7-dimethoxy-1-(4-methoxy-phenethyl)-2-methyl-1,2,3,4-tetrahydro-isoquinoline;2-Methyl-6,7-dimethoxy-1-<2-(4-methoxy-phenyl)-ethyl>-1,2,3,4-tetrahydro-isochinolin
6,7-dimethoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline化学式
CAS
30001-98-0
化学式
C21H27NO3
mdl
——
分子量
341.45
InChiKey
YHCFVRGEXOWJSW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    459.1±45.0 °C(Predicted)
  • 密度:
    1.075±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.87
  • 重原子数:
    25.0
  • 可旋转键数:
    6.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    30.93
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

反应信息

  • 作为产物:
    描述:
    2,3-二溴-3-(4-甲氧基-苯基)-丙酸 在 5%-palladium/activated carbon 、 氢气 、 sodium carbonate 、 potassium hydroxide 、 偶氮二甲酸二乙酯 作用下, 以 四氢呋喃乙醇 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 1.0h, 生成 6,7-dimethoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline
    参考文献:
    名称:
    C-1 Alkynylation of N-Methyltetrahydroisoquinolines through CDC: A Direct Access to Phenethylisoquinoline Alkaloids
    摘要:
    本文介绍了一种使用CuI-DEAD的N-甲基四氢异喹啉与炔烃之间的直接交叉偶联反应,该反应以高产率选择性地生成了C-1位炔基化的产物。这种区域选择性与先前报道的N,N-二甲基苄胺反应结果形成鲜明对比,后者几乎完全或主要生成N-甲基炔基化产物。C-1位取代的丙炔基异喹啉能通过Pd/C催化轻易还原为苯乙基异喹啉。这一反应序列提供了一条合成甲氧啡啉、同劳丹诺素及其他苯乙基异喹啉生物碱的简捷途径。
    DOI:
    10.1055/s-0031-1290532
点击查看最新优质反应信息

文献信息

  • C-1 Alkynylation of N-Methyltetrahydroisoquinolines through CDC: A Direct Access to Phenethylisoquinoline Alkaloids
    作者:Kamal Singh、Paramjit Singh、Amarjit Kaur、Pushpinder Singh
    DOI:10.1055/s-0031-1290532
    日期:2012.3
    Direct cross-coupling between N-methyltetrahydroisoquinolines and alkynes using CuI-DEAD is presented. It affords the regioselective C-1-alkynylated products in good yield. This regio­selectivity is in contrast to the results reported earlier in the reaction of N,N-dimethylbenzyl amine where the N-methyl alkynylated product was formed exclusively or predominantly. The C-1-substituted propargylic isoquinolines were easily reduced to phenethylisoquinolines with Pd/C. This reaction sequence provides a short route to synthesize methopholine, homolaudanosine and other phenethylisoquinoline alkaloids.
    本文介绍了一种使用CuI-DEAD的N-甲基四氢异喹啉与炔烃之间的直接交叉偶联反应,该反应以高产率选择性地生成了C-1位炔基化的产物。这种区域选择性与先前报道的N,N-二甲基苄胺反应结果形成鲜明对比,后者几乎完全或主要生成N-甲基炔基化产物。C-1位取代的丙炔基异喹啉能通过Pd/C催化轻易还原为苯乙基异喹啉。这一反应序列提供了一条合成甲氧啡啉、同劳丹诺素及其他苯乙基异喹啉生物碱的简捷途径。
查看更多

同类化合物

1-<2-(4-羟基-3-甲氧基)乙基>-7-羟基-6-甲氧基-1,2,3,4-四氢异喹啉 (1R)-1-(4-methoxyphenyl)-2-<(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1R)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1S)-1-(4-methoxyphenyl)-2-<(1S)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol (1S)-1-(4-methoxyphenyl)-2-<(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolyl>ethanol Isoautumnaline 6-benzyloxy-1-(3-benzyloxy-4,5-dimethoxyphenethyl)-7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline 7-Benzyloxy-6-methoxy-2-methyl-1-(4-methoxy-phenethyl)-1,2,3,4-tetrahydro-isochinolin 1-(4-methoxyphenethyl)-1,2,3,4-tetrahydro-6-methoxy-2-methyl-7-isoquinolinol (+)-colchiethine 7-hydroxy-6-methoxy-1-(3',4',5'-trimethoxyphenethyl)-N-methyl-1,2,3,4-tetrahydroisoquinoline (+)-colchiethanamine (+/-)-N,N-Dimethyl-6,7,3',4'-tetramethoxyphenylethyl-1,2,3,4-tetrahydroisoquinolinium iodide [(1S)-7-methoxy-1-[2-(4-methoxyphenyl)ethyl]-2-methyl-3,4-dihydro-1H-isoquinolin-6-yl] 2,2-dimethylpropanoate [4-[2-[(1S)-6-(2,2-dimethylpropanoyloxy)-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]ethyl]phenyl] 2,2-dimethylpropanoate (1S)-6,7-dimethoxy-2-methyl-1-[2-(3,4,5-trimethoxyphenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline (S)-autumnaline 6,7-dimethoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline 1,2,3,4-tetrahydro-6-hydroxy-7-methoxy-1-(2-(3',4'-dimethoxyphenyl)ethyl)-2-methylisoquinoline (S)-(+)-homolaudanosine (-)-Homolaudanosine (1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1S)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1R)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (S)-1-[2-(4-Hydroxy-phenyl)-ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-7-ol (1R)-1-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-7-ol (1S)-1-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol N-Methyl-1-(3,5-dimethoxy-4-hydroxy-phenethyl)-2-methyl-7-hydroxy-6-methoxy-1,2,3,4-tetrahydro-isochinolin (1R)-1-[2-(4-hydroxy-3,5-dimethoxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol (1S)-1-[2-[4-[[(1R)-1-[2-(4-hydroxyphenyl)ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenyl]ethyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol 1-{2-[4-({1-[2-(4-Hydroxyphenyl)ethyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)phenyl]ethyl}-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol 1-[2-(4-hydroxyphenyl)ethyl]-7-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-6-ol 7-Hydroxy-1-(3-hydroxy-4,5-dimethoxy-phenethyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin 7-Hydroxy-1-(4-hydroxy-phenethyl)-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isochinolin, 1-<2-(p-Hydroxy-phenyl)-ethyl>-2-methyl-6-methoxy-7-hydroxy-1,2,3,4-tetrahydro-isochinolin (+/-)-isoautumnaline homolaudanosine 7-methoxy-1-(4-methoxyphenylethyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-6-ol